Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements
- PMID: 16516243
- DOI: 10.1016/j.lfs.2005.12.020
Proposed rule: current good manufacturing practice in manufacturing, packing, or holding dietary ingredients and dietary supplements
Abstract
The Dietary Supplement Health and Education Act (DSHEA) was enacted in October 1994 to promote the health of Americans by ensuring easier access to safe dietary supplements. Many supplements such as vitamins, minerals, herbs and amino acids have been reported to be helpful in chronic conditions (i.e., heart disease, cancer and osteoporosis). Under DSHEA, dietary supplements can be marketed without prior FDA approval; the burden is on this agency to show that a marketed dietary supplement is unsafe. However, DSHEA retained the FDA's authority to issue regulations that require the manufacture of dietary supplements be in compliance with current good manufacturing practice (cGMP) standards, which are needed to ensure their quality. Several quality-related concerns of marketed dietary supplements that came to light since the passage of DSHEA prompted the FDA in 2003 to propose rules for cGMP for the manufacture, packaging and holding (storage) of dietary supplements. This review will present the highlights of these proposed rules, focusing on the legislative history of DSHEA, rationale for proposing cGMPs along with a general discussion of the specific requirements. Given the voluminous nature of the specific details, the reader is directed to the pertinent FDA publications for details. In this analysis, selected scientific and legal issues are also discussed to promote a better understanding and implications of these rules.
Similar articles
-
Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.Fed Regist. 2007 Jun 25;72(121):34751-958. Fed Regist. 2007. PMID: 17674484
-
Petition to request an exemption from 100 percent identity testing of dietary ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. Interim final rule.Fed Regist. 2007 Jun 25;72(121):34959-69. Fed Regist. 2007. PMID: 17674485
-
FDA regulation of dietary supplements and requirements regarding adverse event reporting.Clin Pharmacol Ther. 2010 Feb;87(2):239-44. doi: 10.1038/clpt.2009.263. Epub 2009 Dec 23. Clin Pharmacol Ther. 2010. PMID: 20032973
-
Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.J Herb Pharmacother. 2005;5(3):67-86. J Herb Pharmacother. 2005. PMID: 16520299 Review.
-
Dietary supplements and lessons to be learned from GRAS.Regul Toxicol Pharmacol. 2000 Feb;31(1):68-76. doi: 10.1006/rtph.1999.1369. Regul Toxicol Pharmacol. 2000. PMID: 10715226 Review.
Cited by
-
Advancing herbal medicine: enhancing product quality and safety through robust quality control practices.Front Pharmacol. 2023 Sep 25;14:1265178. doi: 10.3389/fphar.2023.1265178. eCollection 2023. Front Pharmacol. 2023. PMID: 37818188 Free PMC article. Review.
-
Menaquinone 7 Stability of Formulations and Its Relationship with Purity Profile.Molecules. 2019 Feb 26;24(5):829. doi: 10.3390/molecules24050829. Molecules. 2019. PMID: 30813554 Free PMC article.
-
Testosterone Imposters: An Analysis of Popular Online Testosterone Boosting Supplements.J Sex Med. 2019 Feb;16(2):203-212. doi: 10.1016/j.jsxm.2018.12.008. J Sex Med. 2019. PMID: 30770069 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical